Optical Genome Mapping Market, valued at USD 108.3 Million in 2023, is projected to surpass USD 772.7 Million by 2032, indicating a robust CAGR of 24.9%

Optical genome mapping (OGM) is a powerful technique used in genomics to analyze the structure and organization of an organism's genome. It involves the use of high-resolution imaging to map the physical location of DNA molecules within a genome. Applications of optical genome mapping include identifying large-scale genomic rearrangements, such as insertions, deletions, and inversions, which are crucial for understanding genetic diseases, cancer development, and evolutionary processes. OGM also aids in genome assembly and, assisting in the construction of high-quality reference genomes for various organisms. Additionally, it can be used for studying epigenetic modifications and chromatin structure, further expanding its utility in genome function and regulation. Overall, optical genome mapping offers a versatile approach for comprehensive genomic analysis with wide-ranging applications in research, diagnostics, and biotechnology. However, high cost of instruments and services became a restraint for the optical genome mapping market. Furthermore, genomic research initiatives and government initiatives in genome mapping for innovative developments prompted the optical genome mapping market. As a consequence, market participants are looking into new advancements in the optical genome mapping market.

Optical Genome Mapping Vehicle Market Statistics

• The global optical genome mapping market, generating USD 108.3 Million in 2023, projects a robust CAGR exceeding 24.9% from 2024 to 2032
• North America leads with a substantial 43% market share in 2022
• Asia-Pacific anticipates impressive growth with a projected CAGR of 25.5%
• Based on solution, structural variant detection sub-segment accomplished 48% of share in 2023
• A discernible trend in the optical genome mapping market is technological advancements in genome mapping

Download Sample Report Copy: https://www.acumenresearchandconsulting.com/request-sample/3796

Optical Genome Mapping Vehicle Market Dynamics

Increasing Demand for Personalized Medicines Fuels the Optical Genome Mapping Market Value

Increasing demand of the personalized medicines drives the growth of optical genome mapping market during the forecast period 2024 to 2032. As people become more conscious of their nutritional needs there's a growing demand for personalized medicines. Personalized medicines offer convenience making them an effective option for those looking for unique dietary gaps or preferences. This trend reflects towards personalized healthcare and wellness, where consumers are looking for the personalized medicines. Furthermore, development of new genomic technologies further contribute the market demand. As a result, the optical genome mapping market is experiencing steady growth, fueled by the increasing demand of the personalized medicines.

Advancements in Optical Mapping Technology Offer Significant Optical Genome Mapping Market Opportunity

Technological advancements in the genome mapping technologies create an opportunity for the optical genome mapping market. The collaboration between key players further contributes to the growth of optical genome mapping market. For instance, Cerba HealthCare is agreeing to purchase Viroclinics-DDL from Summit Partners. It’s a rapidly developing global virology and immunology contract research organization (CRO) on December 2021. These advancements create an accuracy, speed and scalability of overall performance. Key players are also focus on the latest research and development activities in the OGM market. Therefore, technological innovations and advancements in genome mapping become an significant opportunity for the OGM market in the coming years.

Optical Genome Mapping Vehicle Market Segmentation

The global market for optical genome mapping has been segmented into product, solution, application, end-users, and region.

• Product is classified into instruments, consumables and reagents, and software and services
• Solution is divided into structural variant detection, genome assembly, microbial strain typing, and others
• Applications are bifurcated into research and diagnostics
• End-users categorized into biotechnology and pharmaceutical companies, clinical laboratories, academic research institutes, and others
• The optical genome mapping market is geographically split into Europe, North America, Latin America, APAC, and the Middle East and Africa

Optical Genome Mapping Vehicle Market Regional Outlook

In terms of optical genome mapping market analysis, North America dominates the optical genome mapping market. With the growing focus on research and development activities North America is at leading position in this market. For instance, Nabsys, a genome analysis technology focused on the human genome and has secured an extra $13 million from Hitachi High-Technologies. The strong healthcare infrastructure and pharmaceutical institutes further contributes to the market growth. Increasing demand for personalized medicines in the countries like U.S, Canada, and Mexico which further propel the growth in this region. As a result, regions strong emphasis on healthcare infrastructure maintains its dominance in the optical genome mapping market.

Asia-Pacific is the fastest-growing region in the optical genome mapping market due to the robust healthcare infrastructure, presence of pharmaceutical institutions in the countries like China, India, Japan, Australia and South Korea. Furthermore, key players in this region are focus on advancements in optical mapping technology which maintain Asia-Pacific’s position in the market. For instance, Optical Genome Mapping that is cutting-edge high-end next-generation genetic testing tool launched by the Centre for Cellular & Molecular Biology (CCMB) in Hyderabad, India on July 2023.

Optical Genome Mapping Vehicle Market Players

Optical genome mapping companies profiled in the report include Bionano Genomics, Hofkens Lab, Nucleome Informatics Private Limited, Genohub Inc, Praxis Genomics, LLC, PerkinElmer (PerkinElmer Genomics), SourceBio International Limited (Source BioScience), Cerba HealthCare, INRAE (French Plant Genomic Resources Center (CNRGV)) and OpGen, Inc.

Buy Now This Report: https://www.acumenresearchandconsulting.com/buy-now/0/3796

Optical Genome Mapping Market Key Insights

Mr. Richard Johnson

Acumen Research and Consulting

India: +91 8983225533

E-mail: [email protected]